Free Trial

15,573 Shares in Genpact Limited (NYSE:G) Purchased by Fox Run Management L.L.C.

Genpact logo with Business Services background

Fox Run Management L.L.C. purchased a new position in shares of Genpact Limited (NYSE:G - Free Report) during the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor purchased 15,573 shares of the business services provider's stock, valued at approximately $669,000.

A number of other hedge funds have also recently added to or reduced their stakes in the stock. SRH Advisors LLC bought a new position in Genpact in the 4th quarter valued at $26,000. Manchester Capital Management LLC bought a new position in Genpact in the fourth quarter valued at about $38,000. Smartleaf Asset Management LLC boosted its holdings in Genpact by 416.5% in the fourth quarter. Smartleaf Asset Management LLC now owns 971 shares of the business services provider's stock valued at $41,000 after acquiring an additional 783 shares during the last quarter. UMB Bank n.a. raised its holdings in Genpact by 55.7% during the 4th quarter. UMB Bank n.a. now owns 1,210 shares of the business services provider's stock worth $52,000 after purchasing an additional 433 shares during the last quarter. Finally, J.Safra Asset Management Corp lifted its position in Genpact by 38.8% during the 4th quarter. J.Safra Asset Management Corp now owns 1,622 shares of the business services provider's stock valued at $69,000 after purchasing an additional 453 shares during the period. Institutional investors own 96.03% of the company's stock.

Genpact Trading Down 1.5 %

Shares of G traded down $0.75 during trading hours on Friday, reaching $50.00. The stock had a trading volume of 1,088,529 shares, compared to its average volume of 1,355,537. The firm has a 50-day moving average of $50.84 and a 200 day moving average of $45.02. The company has a quick ratio of 1.85, a current ratio of 2.16 and a debt-to-equity ratio of 0.50. The company has a market cap of $8.78 billion, a P/E ratio of 17.61, a P/E/G ratio of 1.84 and a beta of 1.16. Genpact Limited has a 52 week low of $30.23 and a 52 week high of $56.76.

Genpact (NYSE:G - Get Free Report) last announced its quarterly earnings results on Thursday, February 6th. The business services provider reported $0.82 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.86 by ($0.04). Genpact had a return on equity of 22.50% and a net margin of 10.77%. On average, sell-side analysts expect that Genpact Limited will post 3.21 earnings per share for the current fiscal year.

Genpact Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Wednesday, March 26th. Stockholders of record on Tuesday, March 11th were issued a $0.17 dividend. This represents a $0.68 annualized dividend and a dividend yield of 1.36%. The ex-dividend date of this dividend was Tuesday, March 11th. This is a boost from Genpact's previous quarterly dividend of $0.15. Genpact's dividend payout ratio is 23.94%.

Insider Activity

In other news, SVP Piyush Mehta sold 12,000 shares of the firm's stock in a transaction that occurred on Friday, January 10th. The shares were sold at an average price of $42.83, for a total transaction of $513,960.00. Following the completion of the transaction, the senior vice president now directly owns 151,182 shares of the company's stock, valued at $6,475,125.06. This trade represents a 7.35 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Balkrishan Kalra sold 13,600 shares of the business's stock in a transaction on Thursday, March 13th. The stock was sold at an average price of $48.89, for a total transaction of $664,904.00. Following the completion of the sale, the chief executive officer now directly owns 310,246 shares in the company, valued at approximately $15,167,926.94. This represents a 4.20 % decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 2.80% of the company's stock.

Analyst Ratings Changes

Several equities research analysts have recently commented on G shares. Needham & Company LLC lifted their price target on shares of Genpact from $55.00 to $65.00 and gave the stock a "buy" rating in a research report on Friday, February 7th. TD Cowen raised shares of Genpact from a "hold" rating to a "buy" rating and lifted their target price for the stock from $45.00 to $60.00 in a report on Friday, February 7th. Mizuho increased their price target on Genpact from $45.00 to $55.00 and gave the company a "neutral" rating in a research note on Monday, February 10th. Finally, Jefferies Financial Group raised Genpact from a "hold" rating to a "buy" rating and lifted their price objective for the stock from $44.00 to $55.00 in a research note on Tuesday, January 21st. Six equities research analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. According to MarketBeat, the company currently has a consensus rating of "Hold" and an average target price of $48.44.

Read Our Latest Analysis on G

Genpact Company Profile

(Free Report)

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.

See Also

Institutional Ownership by Quarter for Genpact (NYSE:G)

Should You Invest $1,000 in Genpact Right Now?

Before you consider Genpact, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genpact wasn't on the list.

While Genpact currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Related Videos

Massive Buybacks: 3 Stocks Insiders Are Buying Up
Nuclear Energy’s Comeback: 7 Stocks to Watch in 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines